Get the latest updates on insider buying and selling for ACADIA Pharmaceuticals (NASDAQ:ACAD) today. Stay informed on insider activities and market impact.

Find the latest information on ACADIA Pharmaceuticals Inc. Common Stock ... Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted to insider trading for selling more than 60,000 Acadia ...

Acadia Pharmaceuticals Inc. via AP The former vice president of a San Diego-based pharmaceutical company pleaded guilty Friday to a federal securities fraud count for insider trading.

Acadia Pharmaceuticals Inc (ACAD) latest news, insider trading and hedge fund ownership data provided by Insider Monkey. Log In Sign Up Premium #1 AI Stock to Buy ...

In other recent news, Acadia Pharmaceuticals reported a strong financial performance for the fourth quarter of 2024, with revenue increasing 12% year-over-year to $259.6 million.

In other recent news, Acadia Pharmaceuticals reported a strong financial performance for the fourth quarter of 2024, with revenue increasing by 12% year-over-year to $259.6 million.

Shares in ACADIA Pharmaceuticals (ACAD) increased by 9.95 percent on Wednesday, finishing the year higher at $18.35 apiece following news that it is set to join the S&P SmallCap 600 effective ...

ACADIA PHARMACEUTICALS posted quarterly earnings results on Wednesday, May 7th.The company reported earnings of $0.11 per share, missing estimates of $0.11 by $0.00. The company also reported ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted to insider trading for selling more than 60,000 Acadia shares just before news broke regarding an issue with one of the company ...

Acadia Pharmaceuticals CFO sells shares valued at $51,070 ...